Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Contingent Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹21 Cr₹16 Cr₹22 Cr₹13 Cr₹75 Cr

What is the latest Contingent Liabilities ratio of GLAND PHARMA ?

The latest Contingent Liabilities ratio of GLAND PHARMA is ₹21 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹21 Cr
Mar2024₹16 Cr
Mar2023₹22 Cr
Mar2022₹13 Cr
Mar2021₹75 Cr

How is Contingent Liabilities of GLAND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹21 Cr
37.24
Mar2024 ₹16 Cr
-29.41
Mar2023 ₹22 Cr
72.94
Mar2022 ₹13 Cr
-82.91
Mar2021 ₹75 Cr -

Compare Contingent Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,260.4 Cr -2.3% -7.6% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,705.0 Cr -0.7% 2% -1.7% Stock Analytics
DIVIS LABORATORIES ₹167,091.0 Cr -2.1% -2.8% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,555.0 Cr -0.9% -0.6% 12.2% Stock Analytics
CIPLA ₹120,919.0 Cr -1% -1.2% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,165.0 Cr -0.1% 2.3% 2.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.3%

-7.6%

-4.8%

SENSEX

0.2%

-0.5%

4%


You may also like the below Video Courses